Trial
NCT03417830
Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Amyloidosis
Intervention
GSK2315698 (CPHPC)
Why stopped
Change in benefit/risk profile.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-29